Related Experiment Video
Updated: Jun 13, 2026

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
Published on: November 22, 2019
Data is the currency of R&D, and that currency is now generated and traded globally
Abstract:
Changes in the understanding of biological science, translational research and corporate business models require a corresponding change in the approach to chemical and biological information management. The concept of operations being partitioned into discrete departments for drug discovery is beginning to be replaced by a translational approach to this process. Pharmaceutical business and organizational models are also constantly evolving. Traditional approaches to transactional systems, transferring data up to a departmental data warehouse, are no longer meeting the needs of pharmaceutical scientists and, thus, IT departments are not considered as relevant to the business. These changes and their impact on information systems, as well as some solutions to the challenges faced, are discussed in this editorial.
Related Concept Videos
Introduction to R
Data: Types and Distribution
Distributions in...
The R Chart
R charts are pivotal for pinpointing shifts in process variability. Stability is indicated when all data points remain within the defined upper and lower...
Statistical Software for Data Analysis and Clinical Trials
Drug Discovery: Overview
Interpreting R Charts
An R chart plots the range of subsets of measurements collected from a process. Each point on the chart represents the range—defined as the difference between the maximum and minimum values—of a sample...